7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3-(2-deoxy-α-D-erythro-pentofuranosyl)-3,4-dihydro- (9CI)

7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3-(2-deoxy-α-D-erythro-pentofuranosyl)-3,4-dihydro- (9CI) Struktur
38874-37-2
CAS-Nr.
38874-37-2
Englisch Name:
7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3-(2-deoxy-α-D-erythro-pentofuranosyl)-3,4-dihydro- (9CI)
Synonyma:
8-Aza-a-D-2’-deoxyguanosine;8-Aza-alpha-D-2’-deoxyguanosine;8-Aza-alpha-D-2’-deoxyguanosine;7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3-(2-deoxy-α-D-erythro-pentofuranosyl)-3,4-dihydro- (9CI)
CBNumber:
CB19024945
Summenformel:
C9H12N6O4
Molgewicht:
268.23
MOL-Datei:
38874-37-2.mol

7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3-(2-deoxy-α-D-erythro-pentofuranosyl)-3,4-dihydro- (9CI) Eigenschaften

Dichte
2.29±0.1 g/cm3(Predicted)
pka
8.32±0.20(Predicted)

Sicherheit

7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3-(2-deoxy-α-D-erythro-pentofuranosyl)-3,4-dihydro- (9CI) Chemische Eigenschaften,Einsatz,Produktion Methoden

7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3-(2-deoxy-α-D-erythro-pentofuranosyl)-3,4-dihydro- (9CI) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3-(2-deoxy-α-D-erythro-pentofuranosyl)-3,4-dihydro- (9CI) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
NewCan Biotech Limited
+86-0571-86912261 +8613735419629
sales@newcanbio.com China 9980 58
TargetMol Chemicals Inc.

support@targetmol.com United States 38466 58
Zhengzhou Granlen Sciences, ltd. 0371-85513397
info@granlen.com China 1842 58
TargetMol Chemicals Inc. 15002134094
marketing@targetmol.cn China 19711 58

  • 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 5-amino-3-(2-deoxy-α-D-erythro-pentofuranosyl)-3,4-dihydro- (9CI)
  • 8-Aza-alpha-D-2’-deoxyguanosine
  • 8-Aza-a-D-2’-deoxyguanosine
  • 8-Aza-alpha-D-2’-deoxyguanosine
  • 38874-37-2
Copyright 2019 © ChemicalBook. All rights reserved